Prosecution Insights
Prosecution Insights
8 pending office actions • 2 clients • 7 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 23 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (25%) |
| §103 only | 1 (12%) |
| §112 only | 2 (25%) |
| No statute on record | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLINDERS, JEREMY C | 2 | 64.3% | +15.5% |
| HIBBERT, CATHERINE S | 1 | 59.2% | +48.3% |
| BERTAGNA, ANGELA MARIE | 1 | 44.5% | +46.3% |
| SODERQUIST, ARLEN | 1 | 59.6% | +26.9% |
| HARVEY-BUTLER, AVANDA ELEXA | 1 | — | — |
| IVICH, FERNANDO NMN | 1 | 42.9% | +77.9% |
| HORTH, LISA ANNE | 1 | 61.8% | +44.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 17892804 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | HARVEY-BUTLER, AVANDA ELEXA | 55d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17977733 | METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION | FLINDERS, JEREMY C | 113d overdue |
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | FLINDERS, JEREMY C | 31d overdue |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | IVICH, FERNANDO NMN | 22d overdue |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | SODERQUIST, ARLEN | 1d overdue |
| 17986339 | BORDETELLA DETECTION ASSAY | BERTAGNA, ANGELA MARIE | 20d |
| 17427014 | METHODS FOR DETECTING LEGIONELLA | HORTH, LISA ANNE | 34d |
| 18615987 | HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION | HIBBERT, CATHERINE S | 56d |
| Client (Assignee) | Pending OAs |
|---|---|
| QUEST DIAGNOSTICS INVESTMENTS LLC | 7 |
| CLEVELAND HEARTLAB, INC. | 1 |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1684 | 2 |
| 1658 | 1 |
| 1797 | 1 |
| 1683 | 1 |
| 1678 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18615987 | HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION | Cleveland Heartlab, Inc. | HIBBERT, CATHERINE S | 1658 | Other | Non-Final OA | 56d | Pending | Mar 25, 2024 |
| 17986339 | BORDETELLA DETECTION ASSAY | Quest Diagnostics Investments LLC | BERTAGNA, ANGELA MARIE | 1681 | §112 | Non-Final OA | 20d | Pending | Nov 14, 2022 |
| 17977976 | METHODS FOR QUANTITATION OF INSULIN LEVELS BY MASS SPECTROMETRY | Quest Diagnostics Investments LLC | SODERQUIST, ARLEN | 1797 | Other | Non-Final OA | 1d overdue | Pending | Oct 31, 2022 |
| 17977733 | METHODS FOR DETECTING CYSTIC FIBROSIS MUTATIONS USING MITRA TIP EXTRACTION | Quest Diagnostics Investments LLC | FLINDERS, JEREMY C | 1684 | Other | Non-Final OA | 113d overdue | Pending | Oct 31, 2022 |
| 17942927 | METHODS FOR DETECTING DNA MUTATIONS USING MITRA TIP EXTRACTION | Quest Diagnostics Investments LLC | FLINDERS, JEREMY C | 1684 | §103 | Final Rejection | 31d overdue | Pending | Sep 12, 2022 |
| 17892804 | CIRCULATING MICRORNA AS A MARKER FOR HEPATOCELLULAR CARCINOMA | Quest Diagnostics Investments LLC | HARVEY-BUTLER, AVANDA ELEXA | 1683 | §101 | Non-Final OA | 55d | Pending | Aug 22, 2022 |
| 17610044 | MULTIPLEX ASSAY FOR DETERMINING THE ß-AMYLOID 42/40 RATIO IN HUMAN PLASMA SPECIMENS | Quest Diagnostics Investments LLC | IVICH, FERNANDO NMN | 1678 | §101 | Non-Final OA | 22d overdue | Pending | Nov 09, 2021 |
| 17427014 | METHODS FOR DETECTING LEGIONELLA | Quest Diagnostics Investments LLC | HORTH, LISA ANNE | 1681 | §112 | Final Rejection | 34d | Pending | Jul 29, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial